|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
Statistics, 2017. CA Cancer J Clin. 67:7–30. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Holland EC: Glioblastoma multiforme: The
terminator. Proc Natl Acad Sci USA. 97:pp. 6242–6244. 2000;
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Preusser M, de Ribaupierre S, Wöhrer A,
Erridge SC, Hegi M, Weller M and Stupp R: Current concepts and
management of glioblastoma. Ann Neurol. 70:9–21. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Simopoulos AP: Human requirement for N-3
polyunsaturated fatty acids. Poult Sci. 79:961–970. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Simopoulos AP: Omega-3 fatty acids in
inflammation and autoimmune diseases. J Am Coll Nutr. 21:495–505.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Simopoulos AP: The importance of the ratio
of omega-6/omega-3 essential fatty acids. Biomed Pharmacother.
56:365–379. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Song KS, Jing K, Kim JS, Yun EJ, Shin S,
Seo KS, Park JH, Heo JY, Kang JX, Suh KS, et al:
Omega-3-polyunsaturated fatty acids suppress pancreatic cancer cell
growth in vitro and in vivo via downregulation of Wnt/Beta-catenin
signaling. Pancreatology. 11:574–584. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lim K, Han C, Dai Y, Shen M and Wu T:
Omega-3 polyunsaturated fatty acids inhibit hepatocellular
carcinoma cell growth through blocking beta-catenin and
cyclooxygenase-2. Mol Cancer Ther. 8:3046–3055. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Lim K, Han C, Xu L, Isse K, Demetris AJ
and Wu T: Cyclooxygenase-2-derived prostaglandin E2 activates
beta-catenin in human cholangiocarcinoma cells: Evidence for
inhibition of these signaling pathways by omega 3 polyunsaturated
fatty acids. Cancer Res. 68:553–560. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jeong S, Jing K, Kim N, Shin S, Kim S,
Song KS, Heo JY, Park JH, Seo KS, Han J, et al: Docosahexaenoic
acid-induced apoptosis is mediated by activation of
mitogen-activated protein kinases in human cancer cells. BMC
Cancer. 14:4812014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yun EJ, Song KS, Shin S, Kim S, Heo JY,
Kweon GR, Wu T, Park JI and Lim K: Docosahexaenoic acid suppresses
breast cancer cell metastasis by targeting
matrix-metalloproteinases. Oncotarget. 7:49961–49971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kim N, Jeong S, Jing K, Shin S, Kim S, Heo
JY, Kweon GR, Park SK, Wu T, Park JI, et al: Docosahexaenoic acid
induces Cell death in human non-small cell lung cancer cells by
repressing mTOR via AMPK activation and PI3K/Akt inhibition. Biomed
Res Int. 2015:2397642015.PubMed/NCBI
|
|
13
|
Jing K, Song KS, Shin S, Kim N, Jeong S,
Oh HR, Park JH, Seo KS, Heo JY, Han J, et al: Docosahexaenoic acid
induces autophagy through p53/AMPK/mTOR signaling and promotes
apoptosis in human cancer cells harboring wild-type p53. Autophagy.
7:1348–1358. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shin S, Jing K, Jeong S, Kim N, Song KS,
Heo JY, Park JH, Seo KS, Han J, Park JI, et al: The omega-3
polyunsaturated fatty acid DHA induces simultaneous apoptosis and
autophagy via mitochondrial ROS-mediated Akt-mTOR signaling in
prostate cancer cells expressing mutant p53. BioMed Res Int.
2013:5686712013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Jing K, Shin S, Jeong S, Kim S, Song KS,
Park JH, Heo JY, Seo KS, Park SK, Kweon GR, et al: Docosahexaenoic
acid induces the degradation of HPV E6/E7 oncoproteins by
activating the ubiquitin-proteasome system. Cell Death Dis.
5:e15242014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Zajdel A, Wilczok A, Latocha M, Tarkowski
M, Kokocińska M and Dzierzewicz Z: Polyunsaturated fatty acids
potentiate cytotoxicity of cisplatin in A549 cells. Acta Pol Pharm.
71:1060–1065. 2014.PubMed/NCBI
|
|
17
|
Gleissman H, Johnsen JI and Kogner P:
Omega-3 fatty acids in cancer, the protectors of good and the
killers of evil? Exp Cell Res. 316:1365–1373. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kang JX, Wang J, Wu L and Kang ZB:
Transgenic mice: Fat-1 mice convert n-6 to n-3 fatty acids. Nature.
427:5042004. View
Article : Google Scholar : PubMed/NCBI
|
|
19
|
Gobeil S, Boucher CC, Nadeau D and Poirier
GG: Characterization of the necrotic cleavage of poly(ADP-ribose)
polymerase (PARP-1): Implication of lysosomal proteases. Cell Death
Differ. 8:588–594. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Maiuri MC, Zalckvar E, Kimchi A and
Kroemer G: Self-eating and self-killing: Crosstalk between
autophagy and apoptosis. Nat Rev Mol Cell Biol. 8:741–752. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Jhanwar-Uniyal M, Albert L, McKenna E,
Karsy M, Rajdev P, Braun A and Murali R: Deciphering the signaling
pathways of cancer stem cells of glioblastoma multiforme: Role of
Akt/mTOR and MAPK pathways. Adv Enzyme Regul. 51:164–170. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Schley PD, Jijon HB, Robinson LE and Field
CJ: Mechanisms of omega-3 fatty acid-induced growth inhibition in
MDA-MB-231 human breast cancer cells. Breast Cancer Res Treat.
92:187–195. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Faivre S, Kroemer G and Raymond E: Current
development of mTOR inhibitors as anticancer agents. Nat Rev Drug
Discov. 5:671–688. 2006. View
Article : Google Scholar : PubMed/NCBI
|
|
24
|
Shaw RJ: Glucose metabolism and cancer.
Curr Opin Cell Biol. 18:598–608. 2006. View Article : Google Scholar : PubMed/NCBI
|
